The Lupus Research Alliance, together with the John and Marcia Goldman Foundation, funded a study that led to researchers identifying some 150 medications, approved by the U.S. Food and Drug Administration (FDA) for other diseases, that could be promising treatments for systemic lupus erythematosus (SLE). The study, published in the journal…
GlaxoSmithKline (GSK) announced that it has filed applications with U.S. and European regulatory agencies to extend the approval of Benlysta (belimumab) as a treatment for active, autoantibody-positive systemic lupus erythematosus (SLE) to its newer, subcutaneous formulation. The applications draw on positive results from a Phase 3 study in SLE patients treated by injection with the…
Aurinia Pharmaceuticals recently announced that it will host a lupus nephritis (LN) expert breakfast on Friday, Sept. 30, from in New York, to present recently released results from the AURA-LV trial in patients with active LN. The Phase 2b clinical trial (NCT02141672) is a randomized, controlled double-blind study comparing…
A Letter for Alexander Hello my love. First and foremost, you’re not in trouble. 😉 In fact, I am writing this letter to let you know how proud I am of you and how much I love you . I know its been hell these last few years and I…
The Pharmaceutical Research and Manufacturers of America (PhRMA) and Lupus Foundation of America (LFA) released a new report highlighting the progress in the fight against autoimmune diseases, including lupus. The report, “Medicines in Development for Autoimmune Diseases: A Report on Autoimmune Diseases,” states that America’s biopharmaceutical…
In a recent update on its pivotal Phase 3 clinical trial evaluating Lupuzor (rigerimod) as a potential treatment for lupus, ImmuPharma announced that it was complying with a request to open a trial site in Mauritius so that patients there could participate in the study. According to the company, the leading…
XTL Biopharmaceuticals announced that a patent has been issued covering the Europe Union for its leading drug candidate, hCDR1 (edratide), a potential treatment for systemic lupus erythematosus (SLE). The European Patent Office issue (EP1594434) is titled “Parenteral Formulations of Peptides for the Treatment of Systemic Lupus Erythematosus,” and covers formulations…
It all started 2 months ago … 5,000 mile road trip … before my epic road trip and literally while I was sitting at my doctor’s office. Not only was my body achy but just like every other day, I felt like I had been hit by a truck. All…
Lakeshore Recycling Systems (LRS) will join with the Lupus Society of Illinois (LSI) to raise money and disease awareness through the 2016 Chicago Illinois Lupus Walk. This year’s walk will take place on Sunday, Sept. 18, at Lincoln Park, from 9:00 a.m. to 1:00 p.m. Participants may choose distances of…
A recently released poll shows widespread public support among residents of San Jose, California, in favor of patient access to medical marijuana delivered to their homes — 63% in favor, in fact — as the City Council prepares to begin considering new regulations for businesses working in this area. Medical marijuana is…